trial

Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

NCTId NCT02986490
as of 2026-07-01
at a glance
· Unknown
Enrollment 100 (estimated)
Primary completion 2017-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Status
Unknown
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2014-09
Primary completion
2017-01
Eligibility
ALL · 18 Years

Interventions & indications

Sponsors

Investigators

1
Jean-Luc FAILLIE, MD PhDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2017-01
Status
UNKNOWN
relationships
The graph out of here
drug
indication
investigator